1. Home
  2. CFSB vs BRNS Comparison

CFSB vs BRNS Comparison

Compare CFSB & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CFSB
  • BRNS
  • Stock Information
  • Founded
  • CFSB 1889
  • BRNS 2016
  • Country
  • CFSB United States
  • BRNS United Kingdom
  • Employees
  • CFSB N/A
  • BRNS 130
  • Industry
  • CFSB Major Banks
  • BRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CFSB Finance
  • BRNS Health Care
  • Exchange
  • CFSB Nasdaq
  • BRNS Nasdaq
  • Market Cap
  • CFSB 44.9M
  • BRNS 43.4M
  • IPO Year
  • CFSB N/A
  • BRNS 2021
  • Fundamental
  • Price
  • CFSB $7.15
  • BRNS $1.02
  • Analyst Decision
  • CFSB
  • BRNS Strong Buy
  • Analyst Count
  • CFSB 0
  • BRNS 2
  • Target Price
  • CFSB N/A
  • BRNS $3.00
  • AVG Volume (30 Days)
  • CFSB 5.5K
  • BRNS 39.8K
  • Earning Date
  • CFSB 01-28-2025
  • BRNS 11-06-2024
  • Dividend Yield
  • CFSB N/A
  • BRNS N/A
  • EPS Growth
  • CFSB N/A
  • BRNS N/A
  • EPS
  • CFSB N/A
  • BRNS N/A
  • Revenue
  • CFSB $7,444,000.00
  • BRNS $14,969,000.00
  • Revenue This Year
  • CFSB N/A
  • BRNS $1,803.87
  • Revenue Next Year
  • CFSB N/A
  • BRNS N/A
  • P/E Ratio
  • CFSB N/A
  • BRNS N/A
  • Revenue Growth
  • CFSB N/A
  • BRNS 106.21
  • 52 Week Low
  • CFSB $6.34
  • BRNS $0.80
  • 52 Week High
  • CFSB $7.95
  • BRNS $4.16
  • Technical
  • Relative Strength Index (RSI)
  • CFSB 85.12
  • BRNS 46.17
  • Support Level
  • CFSB $6.77
  • BRNS $0.94
  • Resistance Level
  • CFSB $6.94
  • BRNS $1.11
  • Average True Range (ATR)
  • CFSB 0.10
  • BRNS 0.14
  • MACD
  • CFSB 0.07
  • BRNS -0.00
  • Stochastic Oscillator
  • CFSB 100.00
  • BRNS 24.12

About CFSB CFSB Bancorp Inc.

CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.

Share on Social Networks: